Zachary Spigelman - Concepedia

Author

Zachary Spigelman

Tufts Medical Center

Also Known As

David M. Spector, Z Spigelman, Zachary S. Spigelman, Zachary Simon Spigelman, Zachary Spigelman

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Tufts Medical Center Sorbonne Université Tufts University Inserm Parker Hannifin (United States)

About

Zachary Spigelman is an author at Tufts Medical Center specializing in medicine, allergy, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	193
2	Allergy	1	1	88
3	Immunology	1	1	88
4	Pharmacology	1	1	88
5	Autoimmune Disease	1	1	58

Zachary Spigelman

Publications

900

Citations

H-Index

Page 1

	Year	Citations
Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin A. R. Ahmed, Zachary Spigelman, Lisa A. Cavacini, New England Journal of Medicine	2006	450
A reappraisal of Gaucher disease—diagnosis and disease management algorithms Pramod K. Mistry, Maria Domenica Cappellini, Elena Lukina, American Journal of Hematology	2010	187
Antiproliferative effects of suramin on lymphoid cells. Zachary Spigelman, Amy Dowers, S. I. T. Kennedy, PubMed InflammationSeveral Cell LinesAnti-inflammatoryAllergyImmunotoxicology	1987	88
Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease Laura E. Case, Carl Bjartmar, Claire Morgan, Neuromuscular Disorders Pompe DiseaseTranslational MedicineAutoimmune DiseaseTherapeutic EfficacyMedicine	2014	58
Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up A. Razzaque Ahmed, Shawn Shetty, Srini V. Kaveri, Journal of the American Academy of Dermatology Retrospective StudyRecalcitrant Bullous PemphigoidNovel Protocol	2016	51
First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up A. Razzaque Ahmed, Tegan Nguyen, Srini V. Kaveri, International Immunopharmacology Novel ProtocolDermatologyLine TreatmentMedicinePemphigus Vulgaris	2016	47
2',3'-Dideoxyadenosine is selectively toxic for TdT-positive cells Zachary Spigelman, R. Joel Duff, GP Beardsley, Blood	1988	19

Page 1